Abstract:Chronic low-grade inflammation is a central component in the pathogenesis of obesity-related expansion of adipose tissue and complications in other metabolic tissues. Five different signaling pathways are defined as dominant determinants of adipose tissue inflammation: These are increased circulating endotoxin due to dysregulation in the microbiota-gut-brain axis, systemic oxidative stress, macrophage accumulation, and adipocyte death. Finally, the nucleotide-binding and oligomerization domain (NOD) leucine-rich repeat family pyrin domain-containing 3 (NLRP3) inflammasome pathway is noted to be a key regulator of metabolic inflammation. The NLRP3 inflammasome and associated metabolic inflammation play an important role in the relationships among fatty acids and obesity. Several highly active molecules, including primarily leptin, resistin, adiponectin, visfatin, and classical cytokines, are abundantly released from adipocytes. The most important cytokines that are released by inflammatory cells infiltrating obese adipose tissue are tumor necrosis factor-alpha (TNF-α), interleukin 6 (IL-6), monocyte chemoattractant protein 1 (MCP-1) (CCL-2), and IL-1. All these molecules mentioned above act on immune cells, causing local and then general inflammation. Three metabolic pathways are noteworthy in the development of adipose tissue inflammation: toll-like receptor 4 (TLR4)/phosphatidylinositol-3'-kinase (PI3K)/Protein kinase B (Akt) signaling pathway, endoplasmic reticulum (ER) stress-derived unfolded protein response (UPR), and inhibitor of nuclear factor kappa-B kinase beta (IKKβ)-nuclear factor kappa B (NF-κB) pathway. In fact, adipose tissue inflammation is an adaptive response that contributes to a visceral depot barrier that effectively filters gut-derived endotoxin. Excessive fatty acid release worsens adipose tissue inflammation and contributes to insulin resistance. However, suppression of adipose inflammation in obesity with anti-inflammatory drugs is not a rational solution and paradoxically promotes insulin resistance, despite beneficial effects on weight gain. Inflammatory pathways in adipocytes are indeed indispensable for maintaining systemic insulin sensitivity. Cannabinoid type 1 receptor (CB1R) is important in obesity-induced pro-inflammatory response; however, blockade of CB1R, contrary to anti-inflammatory drugs, breaks the links between insulin resistance and adipose tissue inflammation. Obesity, however, could be decreased by improving leptin signaling, white adipose tissue browning, gut microbiota interactions, and alleviating inflammation. Furthermore, capsaicin synthesized by chilies is thought to be a new and promising therapeutic option in obesity, as it prevents metabolic endotoxemia and systemic chronic low-grade inflammation caused by high-fat diet.

Postprandial Triglyceride-Rich Lipoproteins-Induced Lysosomal Dysfunction and Impaired Autophagic Flux Contribute to Inflammation in White Adipocytes

Obesity-associated Inflammation Triggers an Autophagy–lysosomal Response in Adipocytes and Causes Degradation of Perilipin 1

Postprandial triglyceride-rich lipoproteins promote the adipogenic differentiation of adipose-derived mesenchymal stem cells via the LRP1/caveolin-1/AKT1 pathway

Postprandial lipoproteins and the molecular regulation of vascular homeostasis

Sustained Inflammation Induced by LPS Leads to Tolerable Anorexia and Fat Loss Via Tlr4 in Mice

Obesity Induces Preadipocyte CD36 Expression Promoting Inflammation Via the Disruption of Lysosomal Calcium Homeostasis and Lysosome Function

Reappraisal of Adipose Tissue Inflammation in Obesity

1510-P: Adipocyte MicroRNA-802 Promotes Adipose Tissue Inflammation and Insulin Resistance by Modulating Macrophages in Obesity

Lipidomics of triglyceride-rich lipoproteins derived from hyperlipidemic patients on inflammation

Inflammation‐mediated metabolic regulation in adipose tissue

ApoE and the Role of Very Low Density Lipoproteins in Adipose Tissue Inflammation

Lipopolysaccharide challenge significantly influences lipid metabolism and proteome of white adipose tissue in growing pigs

The Effect and Mechanism of TLR9/KLF4 in FFA-Induced Adipocyte Inflammation

Indispensable role of lipoprotein bound-ApoE in adipogenesis and endocytosis induced by postprandial TRL

Obesity and chronic inflammation in adipose tissue

Chronic low-grade inflammation is involved in TLR4 knockout-induced spontaneous obesity in aged mice

Lysozyme 1 Inflamed CCR2+ Macrophages Promote Obesity-Induced Cardiac Dysfunction

Triglyceride-rich Lipoproteins Induce Adipogenic Differentiation Through an Apolipoprotein E/LRP1/caveolae-dependent Pathway: A Hypothesis for Diet-Induced Obesity

Influence of Lipopolysaccharides on Autophagy and Inflammation in Pancreatic Islet Cells of Mice Fed by High-Fat Diet

TNF-α Induces Mitochondrial Dysfunction in 3T3-L1 Adipocytes

Adipose Tissue Macrophages-derived Exosomal MiR-500a-5p under High Glucose Promotes Adipocytes Inflammation by Suppressing Nrf2 Expression